NCT06656728 CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer
| NCT ID | NCT06656728 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tel-Aviv Sourasky Medical Center |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-09-03 |
| Primary Completion | 2024-09-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-09-03 with a primary completion date of 2024-09-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the researchers is to test whether the CancerenD24 index, an algorithm based on the quantitative value of CD24, CD11b, clinical and laboratory characteristics, developed in the laboratory can help in the early detection of a malignant disease in a population of healthy subjects.
Eligibility Criteria
Inclusion Criteria: 1. Completion of all medical exams and questionnaires including cancer diagnoses, demographic data and other epidemiologic information 2. Willing and able to sign an informed consent 3. Age ≥40 years Exclusion Criteria: 1. Age \< 40 years 2. Pregnancy or breastfeeding 3. Any type of fever 4. Any cancer active at study entry or up to 5 years prior to study entry 5. Polyposis syndromes 6. Inflammatory bowel disease 7. Unwilling or unable to provide informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06656728 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06656728 currently recruiting?
Yes, NCT06656728 is actively recruiting participants. Contact the research team at nadira@tlvmc.gov.il for enrollment information.
Where is the NCT06656728 trial being conducted?
This trial is being conducted at Tel Aviv, Israel.
Who is sponsoring the NCT06656728 clinical trial?
NCT06656728 is sponsored by Tel-Aviv Sourasky Medical Center. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.